Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company's Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymers derived from cellulose ethers, vinyl pyrrolidones, acrylic polymers, polyester and polyurethane-based adhesives, and plant and seed extracts. This segment offers its solutions for the pharmaceutical companies; makers of personal care products, food, and beverages; makers of nutraceuticals and supplements; manufacturers of paint, coatings, and construction materials; packaging and converting markets; and oilfield service companies. Its Intermediates and Solvents produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone that are used as chemical intermediates in the production of engineering polymers and polyurethanes, as well as specialty process solvents used in electronics, pharmaceuticals, water filtration membranes, and others. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
IPO Year:
Exchange: NYSE
Website: ashland.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/1/2025 | Overweight → Equal Weight | Wells Fargo | |
| 3/26/2025 | $68.00 → $71.00 | Neutral → Overweight | Analyst |
| 3/5/2025 | Buy → Neutral | Seaport Research Partners | |
| 8/8/2024 | $90.00 → $89.00 | Underweight → Neutral | JP Morgan |
| 4/11/2024 | $100.00 → $112.00 | Equal Weight → Overweight | Wells Fargo |
| 3/14/2024 | $100.00 → $126.00 | Hold → Buy | Jefferies |
| 3/1/2024 | $108.00 | Outperform | Wolfe Research |
| 6/29/2023 | Outperform → In-line | Evercore ISI | |
| 6/26/2023 | $109.00 → $90.00 | Outperform → Market Perform | BMO Capital Markets |
| 2/2/2023 | $104.00 → $105.00 | Neutral → Underweight | JP Morgan |
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
8-K/A - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
11-K - ASHLAND INC. (0001674862) (Filer)
11-K - ASHLAND INC. (0001674862) (Filer)
11-K - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
10-Q - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
SCHEDULE 13D/A - ASHLAND INC. (0001674862) (Subject)
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that the board of directors has named William C. Whitaker, senior vice president and chief financial officer, Ashland, effective July 18, 2025. Whitaker has been serving as the company's interim chief financial officer. Whitaker joined Ashland in 2015. He has held several positions of increasing responsibility in corporate development, treasury, financial planning and analysis (FP&A) and investor relations. Prior to Ashland, Whitaker held roles outside of the company within private equity and transaction advisory services. He earned a Bachelor's degree in Finance from Ohio State University and h
WILMINGTON, Del., July 16, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its third-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, July 29, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Wednesday, July 30. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, interim chief financial officerDago C
WILMINGTON, Del., July 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Karl Bostaph, senior vice president, operations will retire on October 1, 2025. Bostaph joined Hercules in 1990 which was acquired by Ashland in 2008. Over the course of his career at Ashland, Bostaph held roles in Research and Development, Quality, Engineering and Process Technology, and Manufacturing at multiple U.S. locations. He also spent a portion of his career at manufacturing facilities outside of the United States (US) in several regional and global leadership positions. Last year, Bostaph led operations as the company finalized its portfolio optimization initiatives, and most rec
WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today provided an update on its $60 million manufacturing network optimization plan, a key initiative under its "execute" strategy. As part of ongoing efforts to enhance operational consistency and profitability, and improve the competitive position of core technologies, the company announced the closure of its manufacturing facility in Parlin, New Jersey, and the transfer of its hydroxyethyl cellulose (HEC) production from Parlin to its Hopewell, Virginia plant. This action is a critical step in building larger scale, improving costs across manufacturing sites and delivering the planned HEC network optimization sa
Wilmington, Del., May 28, 2025 (GLOBE NEWSWIRE) -- Ashland will host an Innovation Day for analysts and investors at the company's Bridgewater, New Jersey facility on May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required with options to attend via live webcast or in person. To register, visit the following link: registration page Participants will join Ashland's executive and senior technology leaders for an in-depth review of the latest platform developments and their expanding commercial opportunities. The presentations will detail how these advancements are poised to impact key mark
Valvoline Inc. announces that Kevin Willis will become the Company's next Chief Financial Officer (CFO), effective May 19, 2025Current CFO, Mary Meixelsperger, whose planned retirement was announced October 2024, will remain with the company through a transition periodLEXINGTON, Ky., May 8, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE:VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced that Kevin Willis will succeed Mary Meixelsperger as Valvoline Inc.'s Chief Financial Officer effective May 19. Willis brings significant public company experience to Valvoline including capital markets management, financial systems integrations, and operating efficiency im
WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter. The dividend will be payable on June 15, 2025, to stockholders of record at the close of business on June 1, 2025. As of April 30, 2025, there were 45,696,225 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of
WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan
Sales of $479 million, down 17 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives (collectively, "Portfolio Optimization") reduced overall sales by approximately $67 million or 12 percent versus the prior-year quarter. Excluding these initiatives, sales declined five percent.Income from continuing operations of $30 million, or $0.63 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $46 million, or $0.99 per diluted shareNet income of $31 million, or $0.65 per diluted shareAdjusted EBITDA of $108 million, down 14 percent f
WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Thursday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerKevin Willis, senior vice president and chief financia
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
3 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
3 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
Wells Fargo downgraded Ashland from Overweight to Equal Weight
Analyst upgraded Ashland from Neutral to Overweight and set a new price target of $71.00 from $68.00 previously
Seaport Research Partners downgraded Ashland from Buy to Neutral
JP Morgan upgraded Ashland from Underweight to Neutral and set a new price target of $89.00 from $90.00 previously
Wells Fargo upgraded Ashland from Equal Weight to Overweight and set a new price target of $112.00 from $100.00 previously
Jefferies upgraded Ashland from Hold to Buy and set a new price target of $126.00 from $100.00 previously
Wolfe Research initiated coverage of Ashland with a rating of Outperform and set a new price target of $108.00
Evercore ISI downgraded Ashland from Outperform to In-line
BMO Capital Markets downgraded Ashland from Outperform to Market Perform and set a new price target of $90.00 from $109.00 previously
JP Morgan downgraded Ashland from Neutral to Underweight and set a new price target of $105.00 from $104.00 previously
WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan
Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu
Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE:ASH) by Turnspire Capital Partners LLC ("Turnspire"). Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydratio
WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material commercialization. He is the former executive vice president and chief innovation officer, GAF, former chief technology and innovation officer, Avantor and former chief technology and innovation officer, Celanese Corporation. He will serve on the Board's Environmental, Health, Safety and Quality, and Compensation Committees, effective May 6, 2024. Prior to Celanese, Kulkarni held leadership positions at United Te
WILMINGTON, Del., April 15, 2024 (GLOBE NEWSWIRE) -- Effective today, Ashland Inc. (NYSE:ASH) has announced the appointment of Scott A. Tozier, strategic advisor to the CEO and former executive vice president and chief financial officer of Albemarle Corporation to its Board of Directors. Tozier will serve on the Board's Audit Committee and Environmental, Health, Safety and Quality Committee, each also effective April 15, 2024. Prior to Albemarle, Tozier held several leadership positions at Honeywell International, Inc. and served on the Board of Directors for Garrett Motion, Inc. Tozier is an experienced global executive with strong industry leadership in financial management, mergers and
WILMINGTON, Del., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has announced the appointment of Sanat Chattopadhyay, executive vice president of Merck & Company (NYSE:MRK) to its Board of Directors. Chattopadhyay will serve on the Board's Environmental, Health, Safety, and Quality and Governance and Nominating Committees, effective November 13, 2023. Prior to Merck, Chattopadhyay held leadership positions at Wyeth Pharmaceuticals, Aventis, Hoechst Marion Roussel and Hoechst India. As previously announced, Jay V. Ihlenfeld who has served as a director since 2017, and Brendan M. Cummins, who joined the board in 2012 have decided not to stand for re-election at Ashland's Annua
WILMINGTON, Del., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced that its board of directors has approved the appointment of Robin Lampkin as senior vice president, general counsel and secretary. Lampkin joined Ashland in 1991 and has held various roles throughout her 32-year tenure including tort litigation and global environmental regulatory and remediation. As Ashland's chief compliance officer, she has deep corporate governance experience partnering with a variety of stakeholders on global regulatory compliance, training programs, policy administration and ethics investigations. Lampkin is a strategic advisor for global teams for product safety, sustainab
WILMINGTON, Del., June 26, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced the appointment of Sergio Pedreiro, former chief operating officer, Revlon, to its Board of Directors, effective July 1, 2023. Jay V. Ihlenfeld who has served as a director since 2017, and Brendan M. Cummins, who joined the board in 2012 have decided not to stand for re-election at Ashland's Annual Shareholders Meeting in January 2024. Ihlenfeld is the former senior vice president, 3M Company and member of the environmental, health, safety and quality committee and the governance and nominating committee. Cummins is the former chief executive officer of Ciba Specialty Chemicals and the chair of
WILMINGTON, Del., June 10, 2022 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE:ASH) today announced the appointment of two new directors to its Board as of July 1, 2022: Steve Bishop, former chief executive officer, Procter and Gamble (P&G) consumer health care, and Suzan Harrison, former president, Colgate-Palmolive global oral care. William Dempsey who has served as a director since 2016, and Ricky Sandler, who joined the board in 2020 have decided not to stand for re-election at Ashland's Annual Shareholders Meeting in January 2023. Dempsey is the former executive vice president, global pharmaceuticals, Abbott Laboratories and the current chair of the Board's governance and n
MOREHEAD, Ky., Feb. 09, 2022 (GLOBE NEWSWIRE) -- AppHarvest, Inc. (NASDAQ:APPH, APPHW))), a leading AgTech company, public benefit corporation and Certified B Corp building some of the world's largest high-tech indoor farms to grow affordable, nutritious fruits and vegetables at scale while providing good jobs in Appalachia, announced today the unanimous appointment of J. Kevin Willis as a director of the company, as chair of the board's audit committee and as a member of the nominating and corporate governance committee, effective Feb. 19. Willis currently serves as the Senior Vice President and Chief Financial Officer of Ashland (NYSE:ASH), a global specialty materials company, and join
WILMINGTON, Del., July 16, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its third-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, July 29, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Wednesday, July 30. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, interim chief financial officerDago C
WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter. The dividend will be payable on June 15, 2025, to stockholders of record at the close of business on June 1, 2025. As of April 30, 2025, there were 45,696,225 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of
Sales of $479 million, down 17 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives (collectively, "Portfolio Optimization") reduced overall sales by approximately $67 million or 12 percent versus the prior-year quarter. Excluding these initiatives, sales declined five percent.Income from continuing operations of $30 million, or $0.63 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $46 million, or $0.99 per diluted shareNet income of $31 million, or $0.65 per diluted shareAdjusted EBITDA of $108 million, down 14 percent f
WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Thursday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerKevin Willis, senior vice president and chief financia
Wilmington, Del., March 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that it has completed the sale of its Avoca business to Mane effective March 14, 2025. Financial terms of the transaction were not disclosed. The Avoca business supplies sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin. The Avoca business line represents the last entity from Ashland's previous acquisition of Pharmachem. "The Avoca business is a strong player in the fragrance fixative space, with a dedicated team and attractive manufacturing capabilities to meet customer needs," said Guillermo Novo
Sales of $405 million, down 14 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization initiatives (collectively, "Portfolio Optimization") reduced overall sales by approximately $50 million or 11 percent versus the prior-year quarter. Excluding Portfolio Optimization, sales declined 3 percent versus prior-year quarterLoss from continuing operations of $166 million, or loss of $3.51 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $14 million, or $0.28 per diluted shareNet loss of $165 million, or loss of $3.50 per diluted shareA
WILMINGTON, Del., Jan. 20, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. The dividend is payable on March 15, 2025, to stockholders of record at the close of business on March 1, 2025. As of December 31, 2024, there were 47,182,862 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings,
WILMINGTON, Del., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its first-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, January 28, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, January 29. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerKevin Willis, senior vice president and chief finan
WILMINGTON, Del., Nov. 14, 2024 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. The dividend is payable on December 15, 2024, to stockholders of record at the close of business on December 1, 2024. As of October 31, 2024, there were 47,109,326 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coa
Financial results for fourth-quarter fiscal 20241 Sales of $522 million, up one percent from the prior-year quarterSold nutraceuticals business to Turnspire Capital Partners LLCPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization initiatives reduced overall sales by approximately $24 million or five percent versus the prior-year quarterIncome from continuing operations of $19 million, or $0.39 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $61 million, or $1.26 per diluted shareAdjusted EBITDA of $124 million, up 68 percent from the prior-year quarterAdjusted EBITDA below
SC 13G - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13D/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13D/A - ASHLAND GLOBAL HOLDINGS INC (0001674862) (Subject)